World Health Organization site
Skip Navigation Links

Please fill this short user satisfaction survey


Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 9 January 2023
Main ID:  NCT04421313
Date of registration: 18/05/2020
Prospective Registration: Yes
Primary sponsor: University Hospital, Montpellier
Public title: Fibres Supplementation in Rheumatoid Arthritis SUPER-FIBRES
Scientific title: Supplementation of Rheumatoid Arthritis Patients With Dietary Fibre to Improve Their Gut Microbiota
Date of first enrolment: September 2, 2020
Target sample size: 87
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT04421313
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Claire DAIEN, MD-PhD
Address: 
Telephone: 467332319
Email: c-daien@chu-montpellier.fr
Affiliation: 
Name:     Claire DAIEN
Address: 
Telephone:
Email:
Affiliation:  CHU of Montpellier
Name:     Claire DAIEN
Address: 
Telephone:
Email: c-daien@chu-montpellier.fr
Affiliation: 
Key inclusion & exclusion criteria

General

Inclusion criteria:

- Aged 18 to 85

- Be affiliated to or beneficiary of a French social security scheme

- o No desire for pregnancy for the duration of the study (Effective contraception for
women of reproductive age, for the duration of the study (surgical sterilization,
hormonal contraceptives, barrier method, intrauterine device))

Exclusion criteria:

- Lack of written informed consent after a period of reflection

- Patient involved in other research or research for which the exclusion period has not
ended

- Pregnant or nursing woman

- Type I or II diabetes

- Patient receiving more than 10 mg/d corticosteroids at time of inclusion

- Patient who received corticosteroid infusions in the month prior to randomization

- Unusual consumption (>50% higher than usual consumption) of dietary fibre in the last
72 hours (assessed by food questionnaire)

Patient with Rheumatoid polyarthritis

Inclusion criteria:

- Rheumatoid arthritis meeting ACR/EULAR 2010 criteria

- With moderate clinical activity: DAS28-CRP 3.2 and 5.1

- Patient receiving conventional background treatment at stable doses and should not be
modified during 4-week follow-up

Exclusion criteria:

- Patient treated by targeted RA treatment in the year prior to inclusion

- Patient who received antibiotic therapy within 3 months prior to randomization

Control subjects

Inclusion criteria:

- Patient consulting in the rheumatology department for a mechanical pathology:
osteoarthritis of the limbs or spine, osteoporosis, tendinopathy, fibromyalgia,
algodystrophy or capsulitis.

- Matched to a gender and age PR topic 5 years

Exclusion criteria:

· Patient with autoimmune disease, infection or progressive cancer



Age minimum: 18 Years
Age maximum: 85 Years
Gender: All
Health Condition(s) or Problem(s) studied
Rheumatoid Arthritis
Intervention(s)
Drug: Dietary Fiber Supplementation
Primary Outcome(s)
Evaluation of Short-chain fatty acid (SCFA) [Time Frame: 36 months]
Secondary Outcome(s)
Description of immune cells (regulatory T and B cells, Th17) [Time Frame: 36 months]
Evaluation of heart-rate variability. [Time Frame: 36 months]
Description of the gut microbiota bacteria [Time Frame: 36 months]
Secondary ID(s)
RECHMPL17_0397
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Institut de Génétique Moléculaire de Montpellier
University of Sydney
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history Please fill this short user satisfaction survey